Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Balance Sheet


Vaxcyte Balance Sheet

Vaxcyte's total assets for Q2 2023 were $1.50B, an increase of 49.07% from the previous quarter. PCVX total liabilities were $69.44M for the fiscal quarter, a 9.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 1.01B$ 324.34M$ 392.83M$ 65.70M$ 70.80M
Total Liabilities
$ 52.56M$ 40.32M$ 46.98M$ 172.07M$ 128.53M
Total Equity Gross Minority
$ 953.61M$ 284.02M$ 345.84M$ -106.37M$ -57.73M
Total Capitalization
$ 953.61M$ 284.02M$ 345.84M$ -106.37M$ -57.73M
Preferred Stock Equity
Capital Lease Obligations
-$ 16.78M$ 0.00$ 161.00K$ 458.00K
Currency in USD

Vaxcyte Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis